Associated Press: Perlmutter Cancer Center Oncologist Discusses New Metastatic Breast Cancer Treatment
Photo: Callista Images/Getty
Enhertu, a breast cancer drug that targets the HER2 protein, has been shown to reduce the risk of disease progression or death in people with metastatic disease whose tumors have very low levels of the protein, according to a . Sylvia Adams, MD, director of the Breast Cancer Center at 秘密研究所 Langone Health鈥檚 Perlmutter Cancer Center, enrolled several patients in the study.
鈥淚t鈥檚 a practice-changing study,鈥 says Dr. Adams, also a professor in the at 秘密研究所 Grossman School of Medicine. 鈥淚t addresses a major unmet need for patients who have metastatic breast cancer,鈥 Dr. Adams tells the Associated Press.
Read more from the .
听
听
